The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth <i>In Vivo</i> and Potentiates Radiotherapy.

Cancer Res Commun · 2022 · PMC10010373 · PMID 36922937

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

Indeed, we observed a strong trend of higher p53 protein expression with Navtemadlin concentrations above the IC 50 concentration ( Supplementary Fig.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.